PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,944,897 | -18.9% | 285,082 | +3.0% | 0.00% | 0.0% |
Q2 2023 | $3,630,146 | +21.0% | 276,899 | +3.2% | 0.00% | 0.0% |
Q1 2023 | $3,000,958 | +42.5% | 268,422 | +7.4% | 0.00% | 0.0% |
Q4 2022 | $2,106,117 | -51.7% | 249,836 | -4.6% | 0.00% | -50.0% |
Q3 2022 | $4,365,000 | +19.1% | 261,996 | +5.2% | 0.00% | +100.0% |
Q2 2022 | $3,666,000 | -36.8% | 248,982 | +6.5% | 0.00% | -50.0% |
Q1 2022 | $5,801,000 | -20.8% | 233,786 | +2.4% | 0.00% | 0.0% |
Q4 2021 | $7,320,000 | -8.3% | 228,239 | +2.9% | 0.00% | -33.3% |
Q3 2021 | $7,983,000 | +73.7% | 221,866 | +113.0% | 0.00% | +50.0% |
Q2 2021 | $4,596,000 | +38.1% | 104,156 | +43.2% | 0.00% | +100.0% |
Q1 2021 | $3,327,000 | -32.2% | 72,732 | +2.4% | 0.00% | -50.0% |
Q4 2020 | $4,904,000 | – | 71,041 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |